NSPR logo

InspireMD (NSPR)

Profile

Full Name

InspireMD, Inc.

Ticker Symbol

NSPR

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

April 12, 2011

Indexes

Not included

Website

http://www.inspiremd.com

Employees

85

Key Details

Price

$2.56(-3.76%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.01M(+12.96% YoY)

Annual EPS

-$0.76(+7.32% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.56
NSPR price is $2.56

30-Day Relative Volume

0.27
NSPR 30-day relative volume is 0.27

Price Performance

Price Most recent change

-3.76%
NSPR price was down -3.76% on Apr 11, 2025

Price YTD change

-2.66%
NSPR price is down -2.66% since January 1st

Price 1-year change

+9.4%
NSPR price is up +9.4% year-on-year

Price 3-year change

-16.88%
NSPR price is down -16.88% over the past 3 years

Price Range

Price All-time high

$2167500.00
NSPR price is currently -100.00% below its historical high of $2167500.00

Price 3-year low

$0.81
NSPR price is currently +216.05% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$76.01M
NSPR market capitalization is $76.01 million

Market cap 3-year change

+196.68%
NSPR market capitalization is up +196.68% over the past 3 years

Market cap All-time high

$145.66M
NSPR market capitalization is currently -47.82% below its historical high of $145.66 million

Market cap sector rank

44.62%
NSPR market capitalization is higher than 44.62% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+26.81%
NSPR shares outstanding is up +26.81% year-on-year

Shares Outstanding 3-Year Change

+256.94%
NSPR shares outstanding is up +256.94% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.01
NSPR beta is -0.01

200-day SMA

$2.74
NSPR price is currently -6.50% below its 200-day simple moving average

50-day SMA

$2.84
NSPR price is currently -9.80% below its 50-day simple moving average

RSI

40.00
NSPR 14-day relative strength index is 40.00

Volume

0.27
NSPR 30-day relative volume is 0.27

ATR

$0.20
NSPR average true range is $0.20

10-day Historical Volatility

49.89%
NSPR 10-day historical volatility is 49.89%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$7.01M
NSPR annual revenue is $7.01 million

Revenue Analysts estimate

$8.86M
NSPR annual revenue is currently -20.89% lower than the consensus analysts' forecast

Revenue 1-year change

+12.96%
NSPR annual revenue is up +12.96% year-on-year

Revenue Sector rank

23.96%
NSPR annual revenue is higher than 23.96% of companies in Healthcare sector

EPS

EPS

-$0.76
NSPR annual earnings per share is -$0.76

EPS Analysts estimate

-$0.90
NSPR annual earnings per share is currently -15.08% lower than the consensus analysts' forecast

EPS 1-year change

+7.32%
NSPR annual earnings per share is up +7.32% year-on-year

EPS Sector rank

62.01%
NSPR annual earnings per share is higher than 62.01% of companies in Healthcare sector

Profit

Gross profit

$1.51M
NSPR annual gross profit is $1.51 million

Gross margin

21.49%
NSPR annual gross profit margin is 21.49%

Operating profit

-$33.50M
NSPR annual operating income is -$33.50 million

Operating margin

-478.00%
NSPR annual operating profit margin is -478.00%

Net income

-$32.01M
NSPR annual net profit is -$32.01 million

Net margin

-456.63%
NSPR annual net profit margin is -456.63%

Expenses

Total expenses

$40.51M
NSPR annual total expenses is $40.51 million

Operating expenses

$35.01M
NSPR annual total operating expenses is $35.01 million

Cost of goods sold

$5.50M
NSPR annual cost of goods sold is $5.50 million

Selling, general & administrative expenses

$21.38M
NSPR annual SGA is $21.38 million

Depreciation and amortization

$280.00K
NSPR annual depreciation & amortization is $280.00 thousand

Interest expense

-
NSPR annual interest expense value is unknown

Income tax

$59.00K
NSPR annual income tax is $59.00 thousand

EBIT & EBITDA

EBIT

-$33.50M
NSPR annual earnings before interest & taxes is -$33.50 million

EBITDA

-$33.22M
NSPR annual EBITDA is -$33.22 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$46.81M
NSPR annual total assets is $46.81 million

Non current assets

$6.29M
NSPR annual long term assets is $6.29 million

Current assets

$40.52M
NSPR annual total current assets is $40.52 million

Cash and cash equivalents

$18.92M
NSPR annual cash & cash equivalents is $18.92 million

Accounts receivable

$1.57M
NSPR annual accounts receivable is $1.57 million

Inventory

$2.57M
NSPR annual inventory is $2.57 million

Liabilities

Total liabilities

$10.72M
NSPR annual total liabilities is $10.72 million

Long term liabilities

$3.04M
NSPR annual total long term liabilities is $3.04 million

Current liabilities

$7.68M
NSPR annual total current liabilities is $7.68 million

Accounts payable

$1.25M
NSPR annual accounts payable is $1.25 million

Debt

Total debt

$2.34M
NSPR annual total debt is $2.34 million

Total debt 1-year change

+46.58%
NSPR annual total debt is up +46.58% year-on-year

Long term debt

$1.80M
NSPR annual long term debt is $1.80 million

Short term debt

$542.00K
NSPR annual short term debt is $542.00 thousand

Equity & Capital

Shareholders equity

$36.09M
NSPR annual stockholders equity is $36.09 million

Book value

$36.09M
NSPR annual book value is $36.09 million

Retained earnings

-$253.51M
NSPR annual retained earnings is -$253.51 million

Working capital

$32.84M
NSPR annual working capital is $32.84 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$21.87M
NSPR annual cash flow from operations is -$21.87 million

Cash from operations 1-year change

-33.54%
NSPR annual cash flow from operations is down -33.54% year-on-year

Cash from investing

$12.64M
NSPR annual cash flow from investing activities is $12.64 million

Cash from investing 1-year change

+178.55%
NSPR annual cash flow from investing activities is up +178.55% year-on-year

Cash from financing

$18.45M
NSPR annual cash flow from financing activities is $18.45 million

Cash from financing 1-year change

-50.84%
NSPR annual cash flow from financing activities is down -50.84% year-on-year

CAPEX

CAPEX

$1.40M
NSPR annual capital expenditures is $1.40 million

CAPEX 1-year change

+267.98%
NSPR annual capital expenditures is up +267.98% year-on-year

Free Cash Flow

Free cash flow

-$23.27M
NSPR annual free cash flow is -$23.27 million

Free cash flow 1-year change

-38.87%
NSPR annual free cash flow is down -38.87% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

21.49%
NSPR annual gross profit margin is 21.49%

Operating margin

-478.00%
NSPR annual operating profit margin is -478.00%

Net margin

-456.63%
NSPR annual net profit margin is -456.63%

ROA & ROE

ROA

-67.77%
NSPR annual return on assets is -67.77%

ROE

-84.68%
NSPR annual return on equity is -84.68%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NSPR price to earnings ratio value is unknown

PE ratio Sector rank

-
NSPR price to earnings ratio is unknown

PB Ratio

PB ratio

2.11
NSPR price to book ratio is 2.11

PB ratio Sector rank

64.47%
NSPR price to book ratio is higher than 64.47% of companies in Healthcare sector

PS Ratio

PS ratio

10.84
NSPR price to sales ratio is 10.84

PS ratio Sector rank

80.77%
NSPR price to sales ratio is higher than 80.77% of companies in Healthcare sector

Enterprise value

Enterprise value

$59.43M
NSPR enterprise value is $59.43 million

Enterprise value Sector rank

43.94%
NSPR enterprise value is higher than 43.94% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.79
NSPR EV/EBITDA is -1.79

EV/EBITDA Sector rank

33.42%
NSPR EV/EBITDA is higher than 33.42% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.28
NSPR annual current ratio is 5.28

Quick ratio

4.94
NSPR annual quick ratio is 4.94

Leverage

Debt to equity

0.00
NSPR annual debt to equity ratio is 0.00

Interest coverage ratio

-
NSPR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

1
NSPR piotroski f-score is 1

Altman Z-Score

-4.70
NSPR altman z-score is -4.70

Analyst ratings

Recent major analysts updates

Dec 11, 24 Lake Street
Buy
Nov 2, 23 Piper Sandler
Overweight
Jun 12, 23 Piper Sandler
Overweight
May 17, 23 National Alliance Securities
Buy
Mar 31, 23 Alliance Global Partners
Buy

Institutional Ownership

Similar stocks

SRTS logo
Sensus Healthcare (SRTS)
XGN logo
Exagen (XGN)
ACHV logo
Achieve Life Sciences (ACHV)
TBIO logo
Telesis Bio (TBIO)
SRZN logo
Surrozen (SRZN)
FONR logo
FONAR (FONR)
Whitehawk Therapeutics (WHWK)
ENTX logo
Entera Bio (ENTX)
SY logo
So-Young International (SY)
  • What is the ticker symbol for InspireMD?
  • Does InspireMD pay dividends?
  • What sector is InspireMD in?
  • What industry is InspireMD in?
  • What country is InspireMD based in?
  • When did InspireMD go public?
  • Is InspireMD in the S&P 500?
  • Is InspireMD in the NASDAQ 100?
  • Is InspireMD in the Dow Jones?
  • When was InspireMD's last earnings report?
  • When does InspireMD report earnings?
  • Should I buy InspireMD stock now?

What is the ticker symbol for InspireMD?

The ticker symbol for InspireMD is NASDAQ:NSPR

Does InspireMD pay dividends?

No, InspireMD does not pay dividends

What sector is InspireMD in?

InspireMD is in the Healthcare sector

What industry is InspireMD in?

InspireMD is in the Medical Devices industry

What country is InspireMD based in?

InspireMD is headquartered in United States

When did InspireMD go public?

InspireMD's initial public offering (IPO) was on April 12, 2011

Is InspireMD in the S&P 500?

No, InspireMD is not included in the S&P 500 index

Is InspireMD in the NASDAQ 100?

No, InspireMD is not included in the NASDAQ 100 index

Is InspireMD in the Dow Jones?

No, InspireMD is not included in the Dow Jones index

When was InspireMD's last earnings report?

InspireMD's most recent earnings report was on Mar 12, 2025

When does InspireMD report earnings?

The next expected earnings date for InspireMD is May 14, 2025

Should I buy InspireMD stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page